161 related articles for article (PubMed ID: 25582574)
21. The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia.
Di Paolo A; Polillo M; Capecchi M; Cervetti G; Baratè C; Angelini S; Guerrini F; Fontanelli G; Arici R; Ciabatti E; Grassi S; Bocci G; Hrelia P; Danesi R; Petrini M; Galimberti S
Pharmacogenomics J; 2014 Aug; 14(4):328-35. PubMed ID: 24589908
[TBL] [Abstract][Full Text] [Related]
22. Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hOCT1/SLC22A1).
Hayer M; Bönisch H; Brüss M
Ann Hum Genet; 1999 Nov; 63(Pt 6):473-82. PubMed ID: 11388889
[TBL] [Abstract][Full Text] [Related]
23. Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3.
Haenisch B; Drescher E; Thiemer L; Xin H; Giros B; Gautron S; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):1017-23. PubMed ID: 22806583
[TBL] [Abstract][Full Text] [Related]
24. Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters.
Ming X; Ju W; Wu H; Tidwell RR; Hall JE; Thakker DR
Drug Metab Dispos; 2009 Feb; 37(2):424-30. PubMed ID: 18971316
[TBL] [Abstract][Full Text] [Related]
25. Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling.
Roué G; López-Guerra M; Milpied P; Pérez-Galán P; Villamor N; Montserrat E; Campo E; Colomer D
Clin Cancer Res; 2008 Nov; 14(21):6907-15. PubMed ID: 18980985
[TBL] [Abstract][Full Text] [Related]
26. Evidence that the pregnane X and retinoid receptors PXR, RAR and RXR may regulate transcription of the transporter hOCT1 in chronic myeloid leukaemia cells.
Austin G; Holcroft A; Rinne N; Wang L; Clark RE
Eur J Haematol; 2015 Jan; 94(1):74-8. PubMed ID: 25039279
[TBL] [Abstract][Full Text] [Related]
27. The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4alpha.
Saborowski M; Kullak-Ublick GA; Eloranta JJ
J Pharmacol Exp Ther; 2006 May; 317(2):778-85. PubMed ID: 16436500
[TBL] [Abstract][Full Text] [Related]
28. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
[TBL] [Abstract][Full Text] [Related]
29. A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes.
Sogame Y; Kitamura A; Yabuki M; Komuro S
Biopharm Drug Dispos; 2009 Nov; 30(8):476-84. PubMed ID: 19768675
[TBL] [Abstract][Full Text] [Related]
30. Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family.
Chen Y; Zhang S; Sorani M; Giacomini KM
J Pharmacol Exp Ther; 2007 Aug; 322(2):695-700. PubMed ID: 17495125
[TBL] [Abstract][Full Text] [Related]
31. Human organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobials.
Mulgaonkar A; Venitz J; Gründemann D; Sweet DH
Antimicrob Agents Chemother; 2013 Jun; 57(6):2705-11. PubMed ID: 23545524
[TBL] [Abstract][Full Text] [Related]
32. Bendamustin-Rituximab Combination Is a Safe and Effective, Ambulatory Treatment for Elderly Patients with Chronic Lymphocytic Leukemia: Retrospective Real-world Analysis by Age from a German Registry and Review of the Literature.
Kleeberg UR; Linde H; Günther G; Tessen HW; Kersting M
Anticancer Res; 2016 Jun; 36(6):2827-38. PubMed ID: 27272794
[TBL] [Abstract][Full Text] [Related]
33. Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions.
Arimany-Nardi C; Minuesa G; Keller T; Erkizia I; Koepsell H; Martinez-Picado J; Pastor-Anglada M
Front Pharmacol; 2016; 7():175. PubMed ID: 27445813
[TBL] [Abstract][Full Text] [Related]
34. The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin.
Andreev E; Brosseau N; Carmona E; Mes-Masson AM; Ramotar D
Sci Rep; 2016 Feb; 6():20508. PubMed ID: 26861753
[TBL] [Abstract][Full Text] [Related]
35. OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patients.
Koren-Michowitz M; Buzaglo Z; Ribakovsky E; Schwarz M; Pessach I; Shimoni A; Beider K; Amariglio N; le Coutre P; Nagler A
Eur J Haematol; 2014 Apr; 92(4):283-8. PubMed ID: 24215657
[TBL] [Abstract][Full Text] [Related]
36. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia.
Schwänen C; Hecker T; Hübinger G; Wölfle M; Rittgen W; Bergmann L; Karakas T
Leukemia; 2002 Oct; 16(10):2096-105. PubMed ID: 12357363
[TBL] [Abstract][Full Text] [Related]
37. Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia.
Molina-Arcas M; Bellosillo B; Casado FJ; Montserrat E; Gil J; Colomer D; Pastor-Anglada M
Blood; 2003 Mar; 101(6):2328-34. PubMed ID: 12411296
[TBL] [Abstract][Full Text] [Related]
38. Beta-2 Adrenergic Agonists Are Substrates and Inhibitors of Human Organic Cation Transporter 1.
Salomon JJ; Hagos Y; Petzke S; Kühne A; Gausterer JC; Hosoya K; Ehrhardt C
Mol Pharm; 2015 Aug; 12(8):2633-41. PubMed ID: 25751092
[TBL] [Abstract][Full Text] [Related]
39. Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia.
Maffioli M; Camós M; Gaya A; Hernández-Boluda JC; Alvarez-Larrán A; Domingo A; Granell M; Guillem V; Vallansot R; Costa D; Bellosillo B; Colomer D; Cervantes F
Leuk Res; 2011 Aug; 35(8):1014-9. PubMed ID: 21185600
[TBL] [Abstract][Full Text] [Related]
40. Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.
Fernández Calotti P; Galmarini CM; Cañones C; Gamberale R; Saénz D; Avalos JS; Chianelli M; Rosenstein R; Giordano M
Biochem Pharmacol; 2008 Feb; 75(4):857-65. PubMed ID: 18078872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
